-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Pharvaris, Raises Price Target to $50

Benzinga·09/09/2026 12:13:36
Listen to the news
Wedbush analyst Laura Chico maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $42 to $50.